ChromaDex Announces Agreement to Launch Commercial Joint Venture in Mainland China
The signed agreement establishes beachhead to broadly market and distribute Tru Niagen® to Mainland China’s aging population LOS ANGELES--(BUSINESS WIRE)--$CDXC #NAD--ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced it has entered into an agreement (the “JV Agreement”) to establish a joint venture through…